Handwriting as an Objective Tool to Support the Identification of People With Alzheimer's Disease
HAD
1 other identifier
observational
20
1 country
3
Brief Summary
Alzheimer's disease (AD) is the most common of dementia, and has associated cognitive and motor disorders, with consequences on daily activities, including handwriting. Handwriting has been used to study fine motor control or executive functioning in healthy and unhealthy populations. Changes in this skill are present at different stages of the clinical course of Alzheimer's Disease. The sensorimotor deterioration is observed in handwriting tasks (motion kinematics, such as movement time, speed, and profiles) and brain activity rhythms. Handwriting has been used to study fine motor control or executive functioning in healthy and unhealthy populations, and changes in this skill are present at different stages of the clinical course of dementia. From a theoretical perspective, because sensorimotor deterioration observed in handwriting tasks (motion kinematics, such as movement time, speed, and profiles). Due to the large number of brain areas related to handwriting performance, brain electrical activity analysis can be an early indicator of brain dysfunction. Although there is a lack of validation across healthy and non-healthy populations Electroencephalogram (EEG) measures have the potential for evaluating cognitive performance. This research aims to analyze the suitability of the handwriting assessment protocol, which can contribute to a more in-depth knowledge of this subject and potentially support early identification and treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2023
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 2, 2023
CompletedFirst Submitted
Initial submission to the registry
June 7, 2024
CompletedFirst Posted
Study publicly available on registry
July 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2024
CompletedAugust 9, 2024
June 1, 2024
8 months
June 7, 2024
August 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Stroke
A stroke is a series of lines or curves written in a single letter, i.e., the path traced by the pen on the paper. Traces are analyzed movements that unite a movement pattern. A movement pattern can be segmented using 2 segmentation methods: zero crossings of the velocity profile after the velocity peak or the minimum velocity after the velocity peak. This measure is obtained through the software Movalyzer, during the handwriting tasks.
Baseline
Vertical/horizontal start position
Initial vertical/horizontal position relative to the lower limit of the digitizer area (in cm).
Baseline
Vertical/horizontal size
Vertical vector difference between the start and end of a stroke (in cm).
Baseline
Slant
Segment slope, which is estimated by the orientation of the line by minimizing/reducing the sum of the squares of the perpendicular distances of all pixels to the line through the gravity point (in radians).
Baseline
Reaction time
Is the time from the start of the recording to the start of the trace (in sec).
Baseline
Duration
Time interval between the first and last samples in a stroke/segment (in sec).
Baseline
Pen pressure
Average pen pressure values along a stroke (N/m2).
Baseline
Brain activity
Spectral density mean from the frequency of the three bands (theta, alpha, beta)
Baseline
Secondary Outcomes (3)
Handwriting legibility
Baseline
Handwriting speed
Baseline
Visuomotor integration
Baseline
Study Arms (1)
Group 1: subjects with dementia Group 2: subjects without dementia o Group/Cohort Description [*]
Group 1: subjects over the age of 50, with a diagnosis of dementia according to DSM-5 criteria and proven by neuropsychological assessment. Group 2: subjects over the age of 50, with no cognitive impairment on the neuropsychological assessment and with no previous neurological and/or psychiatric history or other illnesses that could interfere with the collection of writing data.
Eligibility Criteria
Participants will be recruited from Municipal and Community Associations, Senior Universities and Residential Centre for the Elderly
You may qualify if:
- Over 50 years of age
- Portuguese native language
You may not qualify if:
- \- Previous neurological history (e.g. stroke, traumatic brain injury, multiple sclerosis, among others), psychiatric history or other incapacitating illnesses that could interfere with the collection of writing data. (NOTE that neurological disease is accepted in the dementia group, but co-morbidity of previous and actual neurological diseases will be excluded) Cognitively normal group
- Over 50 years of age
- At least three years of schooling
- \- Presence of neurological history (e.g., stroke, traumatic brain injury, multiple sclerosis, among others), psychiatric history, or other incapacitating illnesses that could interfere with the collection of writing data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Évoralead
- NOVA Medical Schoolcollaborator
- Faculdade de Motricidade Humanacollaborator
- University of Lisboncollaborator
Study Sites (3)
Espírito Santo Hospital of Évora
Evora, 7000, Portugal
Casa dos Avós Residence
Ponte de Sôr, 7400, Portugal
Costa Azul Residence
Sesimbra, 2970, Portugal
Related Publications (8)
Yan JH, Rountree S, Massman P, Doody RS, Li H. Alzheimer's disease and mild cognitive impairment deteriorate fine movement control. J Psychiatr Res. 2008 Oct;42(14):1203-12. doi: 10.1016/j.jpsychires.2008.01.006. Epub 2008 Feb 15.
PMID: 18280503BACKGROUNDStergiou N, Harbourne R, Cavanaugh J. Optimal movement variability: a new theoretical perspective for neurologic physical therapy. J Neurol Phys Ther. 2006 Sep;30(3):120-9. doi: 10.1097/01.npt.0000281949.48193.d9.
PMID: 17029655BACKGROUNDPalmis S, Danna J, Velay JL, Longcamp M. Motor control of handwriting in the developing brain: A review. Cogn Neuropsychol. 2017 May-Jun;34(3-4):187-204. doi: 10.1080/02643294.2017.1367654. Epub 2017 Sep 11.
PMID: 28891745BACKGROUNDMorgado J, Rocha CS, Maruta C, Guerreiro M, Martins IP. Cut-off scores in MMSE: a moving target? Eur J Neurol. 2010 May;17(5):692-5. doi: 10.1111/j.1468-1331.2009.02907.x. Epub 2009 Dec 29.
PMID: 20050900BACKGROUNDHarbourne RT, Stergiou N. Movement variability and the use of nonlinear tools: principles to guide physical therapist practice. Phys Ther. 2009 Mar;89(3):267-82. doi: 10.2522/ptj.20080130. Epub 2009 Jan 23.
PMID: 19168711BACKGROUNDGarre-Olmo J, Faundez-Zanuy M, Lopez-de-Ipina K, Calvo-Perxas L, Turro-Garriga O. Kinematic and Pressure Features of Handwriting and Drawing: Preliminary Results Between Patients with Mild Cognitive Impairment, Alzheimer Disease and Healthy Controls. Curr Alzheimer Res. 2017;14(9):960-968. doi: 10.2174/1567205014666170309120708.
PMID: 28290244BACKGROUNDEngel-Yeger B, Hus S, Rosenblum S. Age effects on sensory-processing abilities and their impact on handwriting. Can J Occup Ther. 2012 Dec;79(5):264-74. doi: 10.2182/CJOT.2012.79.5.2.
PMID: 23539771BACKGROUNDDixon RA, Kurzman D, Friesen IC. Handwriting performance in younger and older adults: age, familiarity, and practice effects. Psychol Aging. 1993 Sep;8(3):360-70. doi: 10.1037//0882-7974.8.3.360.
PMID: 8216956BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ana Matias, PhD
University of Évora
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher and Assistant Professor
Study Record Dates
First Submitted
June 7, 2024
First Posted
July 3, 2024
Study Start
December 2, 2023
Primary Completion
July 30, 2024
Study Completion
July 30, 2024
Last Updated
August 9, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Starting 6 months after publication
- Access Criteria
- Researchers who wish to have access to IPD, should contact principal researcher. The request should be done by email, were researchers should indicate: complete name, affiliation, position, and justify their interest. After the request will be evaluated by two of the elements of the research group.
Yes: There is a plan to make IPD and related data dictionaries available. All IPD that underlie results in a publication will be shared. Specifically, data from variables mentioned previously, age, gender, and group label.